CYCLERION THERAPEUTICS, INC. Revenue from Related Parties
CYCLERION THERAPEUTICS, INC. (CYCN) reported Revenue from Related Parties of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2022-02-24
- CYCLERION THERAPEUTICS, INC. revenue from related parties for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. revenue from related parties for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. revenue from related parties for the quarter ending 2020-12-31 was $133.00K.
- CYCLERION THERAPEUTICS, INC. revenue from related parties for the quarter ending 2020-09-30 was $400.00K.
- CYCLERION THERAPEUTICS, INC. revenue from related parties for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CYCLERION THERAPEUTICS, INC. revenue from related parties for fiscal 2020 was $2.30M.
| Period end | Revenue from Related Parties 3 month | Revenue from Related Parties 6 month | Revenue from Related Parties 9 month | Revenue from Related Parties 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | ||
| 2020-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $533.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.28M derived: sum of 3 quarters · filed 2022-02-24 | $2.30M 10-K · filed 2022-02-24 |
| 2020-09-30 | $400.00K 10-Q · filed 2021-11-09 | $1.15M derived: sum of 2 quarters · filed 2021-11-09 | $2.16M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $749.00K 10-Q · filed 2021-07-29 | $1.76M 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $1.01M 10-Q · filed 2021-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |